CellaVision AB (publ) (CLVSF)
OTCMKTS
· Delayed Price · Currency is USD
19.28
-0.63 (-3.16%)
At close: Jan 23, 2025
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of $469.60 million as of June 13, 2025. Its market cap has decreased by -18.07% in one year.
Market Cap
469.60M
Enterprise Value
452.80M
Revenue
74.51M
Ranking
n/a
PE Ratio
30.99
Stock Price
$19.28
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 54.35M to 469.60M, an increase of 764.01%. That is a compound annual growth rate of 12.68%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo, Inc. | 1.59B |
Veradigm | 764.23M |
Elite Pharmaceuticals | 717.88M |
Nika Pharmaceuticals | 708.22M |
Tian'an Technology Group | 637.25M |
CytoDyn | 441.29M |
Northwest Biotherapeutics | 403.72M |
Glass House Brands | 384.13M |